What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.20%Below 5Y avg (0.36%)
Annual Rate
CNY 0.03Paid unknown
Payout Ratio
33.8%Sustainable
Last Ex-Dividend
Jun 17, 2026
The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
9.32BCNY
1.40B · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
165.30x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Revenue (TTM)
2.35BCNY
352.29M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
2.32%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Beta
0.6420x
vs all stocks
Updated Oct 22, 2026
52-Week Change
-7.30%
vs all stocks
Updated Oct 22, 2026
Forward Annual Dividend Yield
0.20%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
9.32BCNY
1.40B · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
8.72BCNY
1.31B · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
165.30x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Forward P/E
48.62x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Price to Sales (TTM)
4.10x
vs Aerospace & Defense peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 3.97×.Updated Oct 22, 2026
Price to Book (MRQ)
2.82x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Enterprise to Revenue
3.71x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Enterprise to EBITDA
65.55x
vs Aerospace & Defense peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 119.53×.Updated Oct 22, 2026
Gross Margin
21.84%
vs Aerospace & Defense peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 19.77%.Updated Oct 22, 2026
Profit Margin
2.32%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Operating Margin
2.54%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Return on Assets (TTM)
0.45%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Return on Equity (TTM)
1.90%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Revenue (TTM)
2.35BCNY
352.29M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
4.08CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
-18.00%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Gross Profit (TTM)
464.55MCNY
69.63M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
72.94MCNY
10.93M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
54.59MCNY
8.18M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
29.30%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
-177.67MCNY
-26.63M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
-266.09MCNY
-39.88M · vs all stocks (USD)
Updated Oct 22, 2026
Forward Annual Dividend Rate
0.0300CNYUpdated Oct 22, 2026
Forward Annual Dividend Yield
0.20%
vs all stocks
Updated Oct 22, 2026
Trailing Annual Dividend Rate
0.0330CNYUpdated Oct 22, 2026
Trailing Annual Dividend Yield
0.20%
vs all stocks
Updated Oct 22, 2026
5-Year Average Dividend Yield
0.36%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
33.78%
vs Aerospace & Defense peers
Updated Oct 22, 2026
Minority Interest (Equity)
38.26MCNYFY2025 · Dec 31, 2025
Revenue
2.44BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.00BCNYFY2025 · Dec 31, 2025
Gross Profit
442.10MCNYFY2025 · Dec 31, 2025
Operating Income
49.47MCNY
7.42M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
53.05MCNYFY2025 · Dec 31, 2025
Income Tax Expense
893.77KCNYFY2025 · Dec 31, 2025
Net Income
52.15MCNYFY2025 · Dec 31, 2025
EBIT
53.87MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
181.16MCNYFY2025 · Dec 31, 2025
Research & Development
183.64MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
37.74MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.12MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
8.07MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
820.50KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0947CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0947CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
539.39MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
539.39MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
52.15MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.07MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-224.16MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-401.79MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.07BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
52.15MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.18MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-333.82MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
56.32MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-177.63MCNYFY2025 · Dec 31, 2025
Sale of Investments
2.97MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-174.66MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
165.62MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-8.33MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-1.77MCNYFY2025 · Dec 31, 2025
Other Financing Charges
1.02BCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
1.18BCNYFY2025 · Dec 31, 2025
Shares Outstanding
582.73MSharesUpdated Oct 22, 2026
Float Shares
286.57MSharesUpdated Oct 22, 2026
% Held by Insiders
51.32%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
6.13%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
1.12BCNY
167.58M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
1.92CNYUpdated Oct 22, 2026
Total Debt (MRQ)
165.96MCNY
24.88M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.0480x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Current Ratio (MRQ)
2.05x
vs Aerospace & Defense peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
5.86CNYUpdated Oct 22, 2026
Total Assets
5.31BCNY
795.39M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
3.61BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.85BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.70BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
160.80MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.69BCNYFY2025 · Dec 31, 2025
Cash
824.61MCNYFY2025 · Dec 31, 2025
Cash Equivalents
251.58MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.08BCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.00BCNYFY2025 · Dec 31, 2025
Inventory
536.27MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.48BCNYFY2025 · Dec 31, 2025
Short-term Debt
61.53MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
25.14MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
582.73MCNYFY2025 · Dec 31, 2025
Retained Earnings
409.87MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.45BCNY
517.48M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.32CNYUpdated Oct 22, 2026
52-Week High
33.55CNYUpdated Oct 22, 2026
52-Week Change
-7.30%
vs all stocks
Updated Oct 22, 2026
Beta
0.6420x
vs all stocks
Updated Oct 22, 2026
50-Day MA
18.34CNYUpdated Oct 22, 2026
200-Day MA
20.51CNYUpdated Oct 22, 2026
Avg 10-Day Volume
14.93MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
26.08MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
0.1000CNYUpdated Oct 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.